These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


344 related items for PubMed ID: 9331134

  • 1. Weekly paclitaxel/cisplatin with concurrent radiotherapy in patients with locally advanced non-small cell lung cancer: a phase I study.
    Comella G, Frasci G, Scoppa G, Guida C, Gravina A, Fiore F, Casaretti R, Daponte A, Ruffolo P, Comella P.
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-113-S12-116. PubMed ID: 9331134
    [Abstract] [Full Text] [Related]

  • 2. Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001.
    Langer CJ, Movsas B, Hudes R, Schol J, Keenan E, Kilpatrick D, Yeung C, Curran W.
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-89-S12-95. PubMed ID: 9331129
    [Abstract] [Full Text] [Related]

  • 3. Weekly paclitaxel and cisplatin with concurrent radiotherapy in locally advanced non-small-cell lung cancer: a phase I study.
    Frasci G, Comella P, Scoppa G, Guida C, Gravina A, Fiore F, Casaretti R, Daponte A, Parziale A, Comella G.
    J Clin Oncol; 1997 Apr; 15(4):1409-17. PubMed ID: 9193333
    [Abstract] [Full Text] [Related]

  • 4. Induction therapy with carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose-escalating conformal radiotherapy in the treatment of locally advanced, unresectable non-small cell lung cancer: preliminary report of a phase I trial.
    Socinski MA, Clark JA, Halle J, Steagall A, Kaluzny B, Rosenman JG.
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-117-S12-122. PubMed ID: 9331135
    [Abstract] [Full Text] [Related]

  • 5. Preliminary analysis of a phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small cell lung cancer.
    Choy H, DeVore RF, Hande KR, Porter LL, Rosenblatt P, Yunus F, Schlabach L, Smith C, Shyr Y, LaPorte K, Johnson DH.
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-21-S12-26. PubMed ID: 9331115
    [Abstract] [Full Text] [Related]

  • 6. Combined-modality therapy for advanced non-small cell lung cancer: paclitaxel and thoracic irradiation.
    Choy H, Yee L, Cole BF.
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):38-44. PubMed ID: 8643969
    [Abstract] [Full Text] [Related]

  • 7. Concurrent paclitaxel/cisplatin with thoracic radiation in patients with stage IIIA/B non-small cell carcinoma of the lung.
    Antonia SJ, Wagner H, Williams C, Alberts M, Hubbell D, Robinson L, Hilstro J, Ruckdeschel JC.
    Semin Oncol; 1995 Aug; 22(4 Suppl 9):34-7. PubMed ID: 7644926
    [Abstract] [Full Text] [Related]

  • 8. Twice-weekly paclitaxel and radiation for stage III non-small cell lung cancer.
    Lau DH, Ryu JK, Gandara DR, Morgan R, Doroshow J, Wilder R, Leigh B.
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-106-S12-109. PubMed ID: 9331132
    [Abstract] [Full Text] [Related]

  • 9. Preliminary analysis of a phase II study of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer.
    Choy H, Safran H.
    Semin Oncol; 1995 Aug; 22(4 Suppl 9):55-7. PubMed ID: 7644929
    [Abstract] [Full Text] [Related]

  • 10. Simultaneous paclitaxel and radiotherapy: initial clinical experience in lung cancer and other malignancies.
    Vogt HG, Martin T, Kolotas C, Schneider L, Strassmann G, Zamboglou N.
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-101-S12-105. PubMed ID: 9331131
    [Abstract] [Full Text] [Related]

  • 11. Weekly paclitaxel and nedaplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer: a phase I/II study.
    Hasegawa Y, Takanashi S, Okudera K, Aoki M, Basaki K, Kondo H, Takahata T, Yasui-Furukori N, Tateishi T, Abe Y, Okumura K.
    Jpn J Clin Oncol; 2004 Nov; 34(11):647-53. PubMed ID: 15613553
    [Abstract] [Full Text] [Related]

  • 12. Paclitaxel (1-hour) and carboplatin (area under the concentration-time curve 7.5) in advanced non-small cell lung cancer: a phase II study of the Fox Chase Cancer Center and its network.
    Langer CJ, Millenson M, Rosvold E, Litwin S, McAleer CA, Bonjo CA, Ozols R.
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-81-S12-88. PubMed ID: 9331128
    [Abstract] [Full Text] [Related]

  • 13. Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junction.
    Safran H, Akerman P, Cioffi W, Gaissert H, Joseph P, King T, Hesketh PJ, Wanebo H.
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):53-7. PubMed ID: 10210540
    [Abstract] [Full Text] [Related]

  • 14. Paclitaxel plus carboplatin and concurrent radiation therapy for patients with locally advanced non-small cell lung cancer.
    Choy H, Akerley W, Safran H, Graziano S, Chung C.
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):117-9. PubMed ID: 9007137
    [Abstract] [Full Text] [Related]

  • 15. Seven-week continuous-infusion paclitaxel plus concurrent radiation therapy for locally advanced non-small cell lung cancer: a phase I study.
    Rosenthal DI, Okani O, Corak J, Kavanaugh D, Kamen B, Vuitch FM, Gazdar AF, Greiner J, Frenkel EF, Carbone DP.
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-96-S12-100. PubMed ID: 9331130
    [Abstract] [Full Text] [Related]

  • 16. One-hour paclitaxel in the treatment of non-small cell lung cancer.
    Hainsworth JD, Greco FA.
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):98-101. PubMed ID: 9007133
    [Abstract] [Full Text] [Related]

  • 17. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.
    Belli L, LeChevalier T, Gottfried M, Adams D, Ruffie P, LeCesne A, Tete L, Pellae-Cosset B.
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):29-33. PubMed ID: 8643967
    [Abstract] [Full Text] [Related]

  • 18. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
    Segawa Y, Ueoka H, Kiura K, Kamei H, Tabata M, Sakae K, Hiraki Y, Kawahara S, Eguchi K, Hiraki S, Harada M.
    Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
    [Abstract] [Full Text] [Related]

  • 19. Phase II study of radiotherapy with three-dimensional conformal boost concurrent with paclitaxel and cisplatin for Stage IIIB non-small-cell lung cancer.
    Kim YS, Yoon SM, Choi EK, Yi BY, Kim JH, Ahn SD, Lee SW, Shin SS, Lee JS, Suh C, Kim SW, Kim DS, Kim WS, Park HJ, Park CI.
    Int J Radiat Oncol Biol Phys; 2005 May 01; 62(1):76-81. PubMed ID: 15850905
    [Abstract] [Full Text] [Related]

  • 20. Phase I/II study of paclitaxel and radiotherapy in non-small cell lung cancer.
    Marangolo M, Emiliani E, Rosti G, Giannini M, Vertogen B, Zumaglini F.
    Semin Oncol; 1996 Dec 01; 23(6 Suppl 16):124-7. PubMed ID: 9007139
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.